Page last updated: 2024-11-11

quercetin 7-rhamnoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

quercetin 7-rhamnoside: has antiviral activity against porcine epidemic diarrhea virus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

quercetin 7-O-alpha-L-rhamnopyranoside : A quercetin O-glycoside that is quercetin attached to a alpha-L-rhamnopyranosyl moiety at position 7 via a glycosidic linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5748601
CHEMBL ID4466394
CHEBI ID76057
MeSH IDM0528520

Synonyms (25)

Synonym
7-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4h-benzopyran-4-one
quercetin-7-alpha-l-rhamnoside
4h-1-benzopyran-4-one, 7-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-
22007-72-3
7-rhamnosylquercetin
vincetoxicoside b
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one
quercetin 7-rhamnoside
quercetin 7-o-alpha-l-rhamnopyranoside
CHEBI:76057
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4-oxo-4h-chromen-7-yl 6-deoxy-alpha-l-mannopyranoside
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4-oxo-4h-chromen-7-yl alpha-l-rhamnopyranoside
AKOS024465053
CHEMBL4466394
quercetin-7-o-rhamnoside
quercetin-7-o-alpha-l-rhamnoside (vincetoxicoside b)
Q27145708
HY-N1448
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
DTXSID00944612
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4-oxo-4h-1-benzopyran-7-yl 6-deoxyhexopyranoside
CS-0016889
MS-28114
7-(alpha-l-rhamnopyranosyloxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4h-1-benzopyran-4-one
vincetoxicosideb
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
alpha-L-rhamnoside
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
tetrahydroxyflavoneAny hydroxyflavone carrying four hydroxy substituents.
quercetin O-glycosideAny glycosyloxyflavone that is an O-glycosylated derivative of quercetin.
flavonolsAny hydroxyflavone in which is the ring hydrogen at position 3 of the heterocyclic ring is replaced by a hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1516908Synergistic antifungal activity against Candida albicans by microbroth dilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (15.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]